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P-Stereogenic bisphosphines with a hydrazine
backbone: from N–N atropoisomerism to double
nitrogen inversion†
Amparo Prades, a Samuel Nu´n˜ez-Pertı´n˜ez, a Antoni Riera *ab and
Xavier Verdaguer *ab
The synthesis of P-stereogenic bisphosphine ligands starting from
a phosphinous acid chiral synthon and hydrazine is reported. The
dialkylation of the hydrazine backbone yielded atropo- and nitrogen
inversion isomers which are in slow exchange. The crystallization of
one of the isomers allowed us to study the reaction kinetics of the
equilibria. The new ligands were tested in the Rh catalysed asymmetric
hydrogenation of various benchmark substrates attaining up to
99% ee.
Developing active and selective chiral catalysts is highly relevant
for the chemical and pharmaceutical industries.1 ‘‘Ligand
engineering’’ is a key approach to generate new and more
eﬃcient catalytic systems. Among the diﬀerent types of ligand,
chiral phosphines have made a key contribution to asymmetric
catalysis, which is one of the most eﬀective synthetic methodo-
logies by which to obtain optically pure compounds.2 Since
the pioneering work of Kagan with DIOP3 and Knowles with
DIPAMP,4 a large number of chiral bisphosphine ligands have
been reported. Among these, P-stereogenic phosphines have
proved to be a privileged class of ligands.5,6 Despite enormous
advances in this field, P-stereogenic ligands are usually made
through a lengthy multistep synthesis. Thus, the search for cost
eﬃcient synthesis of optically pure P-stereogenic ligands is of
key importance.
Our group has recently reported procedures for the synthesis
of optically pure P-stereogenic tert-butylmethylphosphinous
acid borane 1.7 This fragment is highly versatile and has allowed
access to C1 symmetric MaxPHOS
8 andMaxPHOX9 ligands. In this
context, we addressed whether our methodology could also be
amenable for the rapid and eﬃcient synthesis of ligands with C2
symmetry. We hypothesized that the coupling of hydrazine to the
activated phosphinous acid 1 could provide nitrogen analogs of
bis-P* type ligands (Scheme 1).10 Here we report the synthesis of
two borane-protected P-stereogenic hydrazine bisphosphine
ligands derived from hydrazine and 1. In solution, these ligands
are present as a mixture of atropo- and nitrogen inversion isomers
in slow exchange. These ligands were also tested in the Rh
catalyzed asymmetric hydrogenation, attaining selectivities up to
99% ee.
Initially, in order to identify all possible intermediates,
a sequential synthesis was performed, starting from 1 and
Boc-hydrazine (Scheme 2). Phosphinous acid 1 was activated
with Ms2O following our procedure.
7c The reaction with tert-butyl
carbazate at20 1C provided hydrazine 2 (58%) in an SN2@P-type
process. The reaction was stereospecific and occurred with
inversion of configuration at the phosphorus center. The Boc
protecting group was removed using anhydrous HCl in MeOH
to yield phosphino hydrazine 3 in 72% yield. From 3, a second
phosphinous acid coupling provided bisphosphine 4 in 56%
yield. Satisfactory stereocontrol was observed throughout the
syntheses, and meso-4 was not detected. We next attempted the
one-pot preparation of 4 starting from hydrazine and 2 equiva-
lents of phosphinous acid 1. We observed that 4 was assembled
eﬃciently in one step with 82% yield.
To improve the stability of the resulting ligands, we derivatized
4 by alkylation on both nitrogen atoms.11 The methylation
of 4 was achieved by deprotonating hydrazine nitrogen atoms
with sodium hydride and adding an excess of methyl iodide
Scheme 1 Strategy developed for the synthesis of P-stereogenic C2
bisphosphines with a hydrazine backbone.
a Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of
Science and Technology, Baldiri Reixac 10, E-08028, Spain.
E-mail: antoni.riera@irbbarcelona.org, xavier.verdaguer@irbbarcelona.org;
Tel: +34 934034813
b Dept. Quı´mica Inorga`nica i Orga`nica, Seccio´ de Quı´mica Orga`nica,
Universitat de Barcelona, Martı´ i Franque`s 1, E-08028 Barcelona, Spain
† Electronic supplementary information (ESI) available: Experimental procedures,
characterization data and NMR spectra for new compounds; crystallographic data file
in CIF format. CCDC 1533430–1533432. For ESI and crystallographic data in CIF or
other electronic format see DOI: 10.1039/c7cc01944k
Received 14th March 2017,
Accepted 31st March 2017
DOI: 10.1039/c7cc01944k
rsc.li/chemcomm
ChemComm
COMMUNICATION
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
M
ar
ch
 2
01
7.
 D
ow
nl
oa
de
d 
on
 2
0/
04
/2
01
7 
15
:2
4:
27
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View Issue
4606 | Chem. Commun., 2017, 53, 4605--4608 This journal is©The Royal Society of Chemistry 2017
at 55 1C (Scheme 3). The dimethyl derivative 5 was isolated in
90% yield. When allyl bromide was used as the alkylating agent,
only monoalkylated product 6 was obtained in moderate yield
(49%). The dialkylated product was not observed, even when
the reaction temperature was increased and the solvent changed.
At this stage, a large number of electrophiles were also tested;
however, dialkylation products were not detected. A cyclization
reaction was attempted with 1,3-dibromopropane as the alkylating
agent. However, the reaction did not aﬀord the expected pyrazo-
lidine ring. The NMR spectra were in concordance with the
formation of 6, which results from the monoalkylation of 4
followed by base-promoted elimination of HBr. Finally, we
deduced that, by using 3-bromo-2-bromomethyl-1-propene, we
could avoid the undesired E2 type reaction. Indeed, using this
electrophile, the cyclization occurred swiftly, providing the
corresponding pyrazolidine 7 in 77% yield.
1H NMR showed that crystalline 5 was present as a single
compound; however, upon dissolution, it rapidly equilibrated to a
1 : 1 mixture of isomers. Analysis of 5 by thin-layer chromato-
graphy (TLC) on silica provided two spots with retention factors of
0.3 and 0.5 (hexane :AcOEt 8 : 2). However, when the reaction
crude product was eluted through a SiO2 flash column, the two
substances were equally present in all the fractions. 2D-TLC
analysis showed that, even in a quick elution, the two products
could not be isolated. The system re-equilibrated a second time,
with a new set of spots on the TLC appearing for every single spot
in the first elution. This observation suggested that 5 was present
as a mixture of two isomers in slow exchange. A variable tem-
perature 1H-NMR experiment of a solution of 5 in DMSO-d6 was
performed at 25, 40 and 70 1C. During the experiment, the signals
corresponding to the protons of the NCH3 groups of the two
species got closer, but total coalescence was not observed, and at
100 1C the sample decomposed.
The X-ray structure of 5 is depicted in Fig. 1.12 The sum of
the angles around the trisubstituted nitrogen atoms added up
to 360.0 and 359.91, which indicates that the N atoms were
completely planar. The view through the N–N axis shows how
the two N planes are almost perpendicular, the P–N–N–P
torsion angle being 98.01. All these findings sustain that the
two species observed in solution are atropoisomers that arise
from the hampered rotation around the N–N bond caused by
the increased steric hindrance of the phosphorus groups
(Fig. 1c).13 Because of the presence of P-stereogenic centers,
the new axial chirality leads to two distinct diastereoisomers
(RP,RP,Ra)-5 and (RP,RP,Sa)-5, which can be observed as two sets
of signals in the 1H NMR spectrum. As (RP,RP,Sa)-5 was the only
atropoisomer present in the solid state, a kinetics study was
performed to determine the activation energy of the equili-
brium between the two atropoisomers.14 Crystals of (RP,RP,Sa)-5
were dissolved in deuterated chloroform in a NMR tube, and
successive 1H-NMR spectra were collected at specific times.15
After approximately 30 min, the concentrations of the two
atropoisomers were the same. The kinetic data followed a first
order profile for the Sa/Ra equilibrium with kinetic constant
k1 = k  1 = 1.47  103 s1, and a DG‡ of 21 kcal mol1 =
88 kJ mol1. It is commonly assumed that the free energy
barrier between conformational and configurational isomers is
100 kJ mol1, which means that if the interconversion barrier is
higher than 100 kJ mol1, isomers can be isolated. This finding
is in agreement with the observation that atropoisomers
(RP,RP,Sa)-5 and (RP,RP,Ra)-5 can be detected by TLC and NMR
but cannot be isolated using chromatographic techniques at
room temperature.
Similar behavior was observed for pyrazolidine 7. When the
crude product was eluted through a SiO2 flash column, two
isomers in a 1 : 1 ratio could be clearly separated and isolated,
Scheme 2 Sequential and direct synthesis of the C2 bisphosphine
hydrazine 4.
Scheme 3 N-Alkylation of the hydrazine backbone.
Fig. 1 X-Ray structure of (RP,RP,Sa)-5. (a) Perspective and (b) Newman
projection through the N–N axis. ORTEP drawing showing thermal
ellipsoids at 50% probability. (c) Newman projections for the equilibrium
of compound 5. In solution, 5 is present as a mixture of diastereomeric
N–N atropoisomers. In the solid state, only the (RP,RP,Sa) atropoisomer is
observed.
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as confirmed by 1H NMR. However, the samples underwent
equilibration within 24 h to the initial 1 : 1 mixture. 1H NMR
analysis showed that, upon crystallization, the crystals contained a
single isomer of 7. X-ray diﬀraction analysis revealed that the unit
cell contained two independent molecules of (RP,RN,RN,RP)-7, both
bearing the phosphorus atoms with the R configuration (Fig. 2).12
The sum of the angles around the nitrogen centers added up to
348.6/351.81 and 336.0/334.71. The geometrical constraints
imposed by the five-membered ring force the nitrogen atoms
to adopt a trigonal pyramidal geometry, with the bulky phos-
phorus groups lying at opposite sides of the pyrazolidine ring,
with a P–N–N–P torsion angle of 122.8/118.61. In this circum-
stance, the isomerization equilibrium can more accurately be
described as a double nitrogen inversion rather than atropoi-
somerism (Fig. 2b). The kinetics of the isomerization of 7 were
also studied by 1H NMR. Upon dissolution of the pure isomers
in CDCl3, almost complete isomerization was observed after
24 h.15 The kinetic constants were calculated to be k1 = k  1 =
1.04  105 s1, with a DG‡ of 24 kcal mol1 (100.4 kJ mol1).
These findings indicate that the energy barrier between
(RP,RN,RN,RP)-7 and (RP,SN,SN,RP)-7 was at the border between
configurational and conformational isomers, in agreement
with the experimental observations.
To date, the use of hydrazine as a backbone for non-chiral
and chiral diphosphines and in catalysis has met limited
success.16 For instance, chiral hydrazine diphosphoramidites
have been described, and their use in the rhodium-catalyzed
hydrogenation of Z-MAC aﬀorded up to 93% enantiomeric
excess.17 With the aim to study the ability of ligands 5 and 7
in catalysis, we proceeded to test them in the Rh catalyzed
asymmetric hydrogenation of standard test substrates.
Heating 5 and 7 with neat pyrrolidine at 80 1C for 2 h
resulted in complete borane deprotection.18 After pyrrolidine
removal, the crude ligand was reacted with [Rh(COD)2][BAr
F
4] to
furnish the desired cationic complexes 8 and 9 (Scheme 4).12,19,20
Asymmetric hydrogenation with catalysts 8 and 9 at 3 bar of H2
and 1 mol% of catalyst loading took place with complete conver-
sions (Table 1). In the reduction of methyl a-acetamidoacrylate
(MAA) catalyst 9, with a pyrazolidine backbone, provided better
enantioselectivity (98% vs. 95% ee, Table 1, entries 1 and 2).
(Z)-Methyl a-acetamido-3-phenylacrylate (Z-MAC) was hydro-
genated to full conversion and almost complete selectivity
(99% ee) with both catalysts (Table 1, entries 3 and 4). The
novel complexes were also active in the hydrogenation of
N-(1-phenylvinyl)acetamide (PVA) yielding full conversion and
enantiomeric excess up to 97% (Table 1, entries 6 and 7).
Reducing the amount of the catalyst to 0.1 mol% of 9 did not
have an adverse eﬀect on the selectivity of the reaction (Table 1,
entry 8). Finally, catalyst 9 proved to be highly active and
selective in the hydrogenation of dimethyl itaconate (DMI),
aﬀording the product with full stereocontrol (99% ee, Table 1,
entry 9). When the catalyst loading was reduced to 0.02 mol%, a
slight decrease in selectivity was observed, and dimethyl itaconate
was isolated in 97% enantiomeric excess (Table 1, entry 10).
In summary, we report a new class of P-stereogenic
C2-symmetric ligands with a hydrazine backbone. The ligands
were assembled from hydrazine and optically pure tert-butyl-
methylphosphinous acid in a rapid and eﬃcient synthesis.
Fig. 2 (a) X-Ray structure of (RP,RN,RN,RP)-7. ORTEP drawing showing one
of the two independent molecules in the unit cell (thermal ellipsoids at
50% probability). (b) Newman projections of the equilibrium for compound 7.
In solution, compound 7 is present as a mixture of diastereomers resulting
from a double nitrogen inversion.
Scheme 4 Borane removal and complexation to Rh(I).
Table 1 Asymmetric hydrogenation using catalysts 8 and 9a
Entry Catalyst (S/C) Substrateb Conv.c (%) eed (%)
1 8 (100) MAA 99 95
2 9 (100) MAA 99 98
3 8 (100) Z-MAC 99 99
4 9 (100) Z-MAC 99 99
5 9 (100) Z-MATC 99 99
6 8 (100) PVA 99 95
7 9 (100) PVA 99 97
8 9 (1000) PVA 99 97
9 9 (100) DMI 99 99
10 9 (5000) DMI 99 97
a Reaction conditions: 0.7 mmol of substrate and 1 mol% of catalyst
in dry MeOH were placed in a Bu¨chi 250 Miniclave. The system was
charged with 3.0 bar of hydrogen gas and the mixture was stirred for
12 h at r.t. b Methyl a-acetamidoacrylate (MAA), (Z)-methyl a-acetamido-3-
phenylacrylate (Z-MAC), (Z)-methyl a-acetamido-3-(3,4,5-trimethyl-
phenyl)acrylate (Z-MATC), N-(1-phenylvinyl)acetamide (PVA), dimethyl
itaconate (DMI). c Conversion was determined by 1H NMR of the crude
reaction mixture. d Enantiomeric excess determined by chiral GC or
HPLC.
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The borane-protected ligands 5 and 7 were present as a mixture
of atropo- and nitrogen-inversion isomers which are in slow
exchange in solution. The nature of such an equilibrium was
studied through a combination X-ray crystallography and reaction
kinetics. The new ligands were tested in the Rh-catalyzed
asymmetric hydrogenation of benchmark substrates demonstrating
that ligands with a hydrazine backbone can show excellent catalytic
performance.
We thank the MINECO (CTQ2014-56361-P) and IRB Barcelona
for financial support. A. P. thanks AGAUR for a Beatriu de Pino´s
fellowship. IRB Barcelona is the recipient of a Severo Ochoa Award
of Excellence from MINECO (Government of Spain).
Notes and references
1 (a) Asymmetric Catalysis On Industrial Scale: Challenges, Approaches
and Solutions, ed. H. A. Blaser and H. J. Federsel, Wiley-VCH,
Weinheim, Germany, 2010; (b) N. B. Johnson, I. C. Lennon,
P. H. Moran and J. A. Ramsden, Acc. Chem. Res., 2007, 40, 1291;
(c) L. A. Saudan, Acc. Chem. Res., 2007, 40, 1309; (d) H. Shimizu,
I. Nagasaki, K. Matsumura, N. Sayo and T. Saito, Acc. Chem. Res.,
2007, 40, 1385; (e) A. M. Palmer and A. Zanotti-Gerosa, Curr. Opin.
Drug Discovery Dev., 2010, 13, 698; ( f ) P. Etayo and A. Vidal-Ferran,
Chem. Soc. Rev., 2013, 42, 728.
2 (a) Phosphorus Ligands in Asymmetric Catalysis, ed. A. Bo¨rner,
Wiley-VCH, Weinheim, Germany, 2008; (b) W. J. Tang and X. M.
Zhang, Chem. Rev., 2003, 103, 3029; (c) W. Zhang, Y. Chi and
X. Zhang, Acc. Chem. Res., 2007, 40, 1278; (d) G. Erre, S. Enthaler,
K. Junge, S. Gladiali and M. Beller, Coord. Chem. Rev., 2008, 252, 471;
(e) H.-U. Blaser, B. Pugin, F. Spindler and M. Thommen, Acc. Chem.
Res., 2007, 40, 1240; ( f ) H. Ferna´ndez-Pe´rez, P. Etayo, A. Panossian
and A. Vidal-Ferran, Chem. Rev., 2011, 111, 2119; (g) O. I.
Kolodiazhnyi, Phosphorus Chemistry I: Asymmetric Synthesis and
Bioactive Compounds, in Topics in Current Chemistry, ed. J. Montchamp,
2015, vol. 360, p. 161.
3 H. B. Kagan and T. P. Dang, J. Am. Chem. Soc., 1972, 94, 6429.
4 W. S. Knowles, M. J. Sabacky, B. D. Vineyard and D. J. Weinkauﬀ,
J. Am. Chem. Soc., 1975, 97, 2567.
5 For reviews on P-stereogenic phosphorus compounds, see:
(a) A. Grabulosa, J. Granell and G. Muller, Coord. Chem. Rev., 2007,
251, 25; (b) O. I. Kolodiazhnyi, Top. Curr. Chem., 2015, 360, 1616;
(c) M. Dutartre, J. Bayardon and S. Juge´, Chem. Soc. Rev., 2016, 45, 5771.
6 For selected applications of this family of phosphines and other
P-stereogenic phosphines, see: (a) G. Xu, W. Fu, G. Liu,
C. H. Senanayake and W. Tang, J. Am. Chem. Soc., 2014, 136, 570;
(b) I.-H. Chen, L. Yin, W. Itano, M. Kanai and M. Shibasaki, J. Am.
Chem. Soc., 2009, 131, 11664; (c) H. Ito, T. Okura, K. Matsuura and
M. Sawamura, Angew. Chem., Int. Ed., 2010, 49, 560; (d) X. Wang
and S. L. Buchwald, J. Am. Chem. Soc., 2011, 133, 19080; (e) Q. Hu,
Z. Zhang, Y. Liu, T. Imamoto and W. Zhang, Angew. Chem., Int. Ed.,
2015, 54, 2260; ( f ) Y. Shibata and K. Tanaka, J. Am. Chem. Soc., 2009,
131, 12552; (g) A. Yanagisawa, S. Takeshita, Y. Izumi and K. Yoshida,
J. Am. Chem. Soc., 2010, 132, 5328; (h) H. Li, K. M. Belyk, J. Yin,
Q. Chen, A. Hyde, Y. Ji, S. Oliver, M. T. Tudge, L.-C. Campeau and
K. R. Campos, J. Am. Chem. Soc., 2015, 137, 13728; (i) R. Tan,
X. Zheng, B. Qu, C. A. Sader, K. R. Fandrick, C. H. Senanayake
and X. Zhang, Org. Lett., 2016, 18, 3346.
7 (a) M. Reve´s, C. Ferrer, T. Leo´n, S. Doran, P. Etayo, A. Vidal-Ferran,
A. Riera and X. Verdaguer, Angew. Chem., Int. Ed., 2010, 49, 9452;
(b) T. Leo´n, A. Riera and X. Verdaguer, J. Am. Chem. Soc., 2011,
133, 5740; (c) S. Orgue´, A. Flores, M. Biosca, O. Pa`mies, M. Die´guez,
A. Riera and X. Verdaguer, Chem. Commun., 2015, 51, 17548.
8 E. Cristo´bal-Lecina, P. Etayo, S. Doran, M. Reve´s, P. Martı´n-Gago,
A. Grabulosa, A. R. Costantino, A. Vidal-Ferran, A. Riera and
X. Verdaguer, Adv. Synth. Catal., 2014, 356, 795.
9 E. Salomo´, S. Orgue´, A. Riera and X. Verdaguer, Angew. Chem., Int.
Ed., 2016, 55, 7988.
10 (a) T. Imamoto, J. Watanabe, Y. Wada, H. Masuda, H. Yamada,
H. Tsuruta, S. Matsukawa and K. Yamaguchi, J. Am. Chem. Soc.,
1998, 120, 1635; (b) I. D. Gridnev, M. Yasutake, N. Higashi and
T. Imamoto, J. Am. Chem. Soc., 2001, 123, 5268; (c) I. D. Gridnev,
Y. Yamanoi, N. Higashi, H. Tsuruta, M. Yasutake and T. Imamoto,
Adv. Synth. Catal., 2001, 343, 118.
11 A. N. Kornev, N. V Belina, V. V Sushev, G. K. Fukin, E. V Baranov,
Y. A. Kurskiy, A. I. Poddelskii, G. A. Abakumov, P. Loennecke and
E. Hey-Hawkins, Inorg. Chem., 2009, 48, 5574.
12 CCDC 1533430 (5), 1533431 (7) and 1533432 (9).
13 To our knowledge there are almost no examples of N–N atropo-
isomerism equilibria. For examples of non-biaryl atropoisomers,
see: E. Kumarasamy, R. Raghunathan, M. P. Sibi and J. Sivaguru,
Chem. Rev., 2015, 115, 11239.
14 Since both nitrogen atoms are completely planar, the new source of
chirality in 5 is an N–N chiral axis. However, it is possible that in the
process of isomerization either one or the two nitrogen atoms adopt
a pyramidal structure.
15 See the ESI† for full details.
16 (a) B. R. Aluri, N. Peulecke, B. H. Mu¨ller, S. Peitz, A. Spannenberg,
M. Hapke and U. Rosenthal, Organometallics, 2010, 29, 226;
(b) A. Bollmann, K. Blann, J. T. Dixon, F. M. Hess, E. Killian,
H. Maumela, D. S. McGuinness, D. H. Morgan, A. Neveling, S. Otto,
M. Overett, A. M. Z. Slawin, P. Wasserscheid and S. Kuhlmann, J. Am.
Chem. Soc., 2004, 126, 14712; (c) A. M. Z. Slawin, M. Wainwright and
J. D. Woollins, J. Chem. Soc., Dalton Trans., 2002, 513.
17 L. Eberhardt, D. Armspach, D. Matt, B. Oswald and L. Toupet,
Org. Biomol. Chem., 2007, 5, 3340.
18 Compound 4 was deboronated in the same conditions. See the ESI†
for experimental details and NMR data on the resulting secondary
diphosphazene.
19 Initial coordination studies were performed using [Rh(COD)2][BF4]
as metal precursor but a mixture of the desired product and a
cationic rhodium complex bearing two bisphosphine ligands was
obtained without possibility to separate them.
20 Complex 9 does not show any dynamic behavior and in solution
behaves as single C2-symmetric compound. X-ray analysis (ESI†)
shows a bite-angle of 82.21 which is slightly smaller than the
corresponding carbon analog bisP*-Rh (83.31), see ref. 10.
Communication ChemComm
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
M
ar
ch
 2
01
7.
 D
ow
nl
oa
de
d 
on
 2
0/
04
/2
01
7 
15
:2
4:
27
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
